Your session is about to expire
← Back to Search
Interstitial Radiation Therapy for Kidney Cancer
Study Summary
This trial is testing a new cancer treatment called interstitial brachytherapy to see if it is effective and has limited side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your total bilirubin level is within the normal range.I can do most of my daily activities without help.My kidney cancer was confirmed through a biopsy.My cancer has not spread to nearby lymph nodes or distant parts of my body.I need urgent treatment for my kidney cancer due to bleeding, pain, or related symptoms.I do not have any uncontrolled illnesses like infections or heart problems.I am a woman who can have children and my pregnancy test before starting therapy was negative.My cancer can be treated with brachytherapy according to my radiation oncologist.I cannot or do not want to have surgery to cure my condition.You need to have a certain number of a type of white blood cells called neutrophils in your blood.I have had surgery or radiation therapy at the site where I will have an operation.I have not received any systemic treatment for kidney cancer.My tumor is mostly solid.I have an untreated cancer that is not kidney cancer.I have a history of unusual bleeding or had a recent bleeding episode.You have enough platelets in your blood, at least 100,000 per microliter.Your AST and ALT levels in your blood are not more than three times the normal limit.My kidney tumor can be treated with a special type of radiation.Your hemoglobin level is higher than 9.I have chosen to receive internal radiation therapy for my kidney cancer.My cancer cannot be treated with targeted destruction methods.My tumor is between 4 and 10 cm in size.My lesion has been growing for over 6 months and is expected to grow more than 4mm a year.Your kidney function must be at least a certain level.My immune system is healthy.
- Group 1: Treatment (interstitial brachytherapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people are currently taking part in this experiment?
"That is correct. The website clinicaltrials.gov indicates that this study, which was created on 16 July 2020 and last updated 18 July 2020, is currently seeking patients. In total, they need 17 individuals at a single location."
Are there any positions available in this clinical trial for new patients?
"That is correct, the information available on clinicaltrials.gov indicates that this trial is still recruiting patients. The study was originally posted on July 16th, 2020 and has since been updated on July 18th, 2022. Currently, there is only 1 site for recruitment but the study is looking for a total of 17 participants."
Share this study with friends
Copy Link
Messenger